SEC Form D filing

Ollin Biosciences, Inc., 2026-06-24

An SEC Form D private-offering notice from Austin, TX, a $330,000,000 filer-stated offering target in Biotech. Filed 2026-06-24. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Ollin Biosciences, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing therapies for vision threatening eye diseases including wet age related macular degeneration and diabetic macular edema, based in Austin, Texas.

Filed 2026-06-24Filed to raise $330,000,000First money in 2026-05-14Raised so far $156,249,990HQ (as filed) Austin, TXSector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified ollin.bio↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source